Session Details

The Impact of Psychoneuroimmunology for Therapeutic Progress: Part 2

Tuesday, 10 February 2004 14:30 -16:00

Harbourside Room

Chairperson Dr Norbert Müller Ludwig-Maximilians-UniversityGermany
Inflammation in psychosis: Experimental therapy
  • Karl Bechter, University of Ulm, Germany
    • Antiinflammatory therapy in schizophrenia and depression
  • Prof Norbert Müller, Psychiatric Hospital, Ludwig-Maximilian-University Munich, Germany
    • The role of IL-1beta in Alzheimer’s disease: Studies on an animal model and therapeutic effects of n-3 fatty acids
  • Cai Song, University of British Columbia, Canada